Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Combined Modality TherapyHematologic NeoplasmsBone Marrow TransplantationBlood Component RemovalStem Cell TransplantationMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsLeukocytes, MononuclearGraft vs Host DiseaseBusulfanMyeloablative AgonistsBone MarrowHematopoietic Stem CellsTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceBone Marrow CellsCarmustineCytophagocytosisHematopoiesisIfosfamideSalvage TherapyStem CellsVincristineAmyloidosisCytarabineHodgkin DiseaseTransplantation ChimeraDisease-Free SurvivalCord Blood Stem Cell TransplantationNeoplasmsTissue DonorsTime FactorsRetrospective StudiesWhole-Body IrradiationSurvival RateSurvival AnalysisInfectionLymphoma, T-CellHistocompatibilityDoxorubicinPlatelet CountT-LymphocytesHistocompatibility TestingBlood CellsImmunosuppressive AgentsRecombinant ProteinsPOEMS SyndromeBone Marrow PurgingLeukemia, Myeloid, AcuteLeukemiaBlood Cell CountPrednisoneCells, CulturedTransplantation, IsogeneicCarboplatinDexamethasoneFlow CytometryFollow-Up StudiesImmunophenotypingVidarabineAntineoplastic AgentsLymphomaCytomegalovirus InfectionsProspective StudiesBone Marrow DiseasesAnemia, AplasticFatal OutcomeGraft vs Leukemia EffectLymphocytesBone and BonesFeasibility StudiesMyelodysplastic SyndromesCell SeparationAntigens, CDLymphocyte ActivationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionLeukocyte CountHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaLiver TransplantationBlood Transfusion, AutologousHematologic Diseases